INTRODUCTION

Lyme Disease    Emerging infectious illnesses cost hundreds of billions of dollars yearly and cause millions of deaths and immense misery, making them a major influence on human communities. The term "emerging infectious diseases" refers to illnesses that develop out of the blue or have a sharp rise in frequency or geographic distribution.

 

  • “Disease emergence in humans in the 1970s and 1980s was caused by the recent mutation in an ape virus that allowed it to invade human bodies and to do so with devastating consequences to the victim” (Ostfeld, 2010).

 Moreover, Global public health is facing a significant challenge from the dynamics of new infectious illnesses, both in terms of the effects on human health and the economy. The extensive effects of these diseases highlight the need for a better comprehension of their causes, modes of transmission, and the complex interactions that occur between pathogens, hosts, and the environment.

 

By exploring the terrain of newly developing infectious illnesses reveals that their unpredictable nature necessitates close monitoring, quick reaction mechanisms, and multidisciplinary co-operation between researchers and medical practitioners. This investigation will focus on Lyme illness as one such well-known case. Lyme disease serves as a typical example of the complex ecological linkages that underlie the formation of diseases and emphasizes the need for comprehensive methods to address and lessen the impact of these complex health concerns on people and communities throughout the world. This analysis seeks to add to the larger conversation on emerging infectious illnesses by highlighting the critical need for a comprehensive strategy to comprehend and manage these risks to human health from a Lyme disease perspective.

 

Conversely, several medical professionals and research teams contend that Lyme disease is comparatively hard to get and manage with oral antibiotics. They worry that non-Lyme disease symptoms and syndromes are commonly misinterpreted as the illness, and that the widely recommended therapies are both useless and perhaps harmful For clients “Patient-advocates and some physicians who treat them are seen as ill informed and out of the mainstream” ( (Ostfeld, 2010)